Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Conferences & Events - 5 days

Mashup Score:70

Emil J Freireich Hematology Grand Rounds The MD Anderson Cancer Center Emil J Freireich Hematology Grand Rounds now has a virtual format. This series...

Patients with polycythemia vera who have controlled hematocrit levels, but elevated white blood counts are at an increased risk of thrombotic events, according to...

Nitin Jain, MD, University of Texas MD Anderson Cancer Center, Houston, TX, gives an overview of the Phase II...

Lymphoma NSSG Page - 5 days

Mashup Score:11

Lymphoma NSSG Resources COVID-19 – For treatment modification guidance click here. It is in the NSSG COVID-19 Protocols/Guidance section. Protocols...

Shernan Holtan, MD, overviews a phase 2 study on human chorionic gonadotropin and epidermal growth factor as treatment for patients with aGVHD, plus a...

Daniel Herranz, PharmD, Ph.D., Assistant Professor in the Department of Pharmacology at the Robert Wood Johnson Medical School & Resident Member...

By Chase Doyle Posted: 1/14/2022 1:37:00 PM Last Updated: 1/14/2022 3:29:05 PM In patients with newly diagnosed acute myeloid leukemia (AML) with an IDH1...

Expert perspective on results from the MASTER trial, which analyzed dara-KRd as frontline therapy with MRD-adapted use in newly diagnosed multiple...

Speaker: Prof. Amer Zeidan, MBBS, MHS, Smilow Cancer Hospital at Yale New Haven, CT, USA Prof. Amer Zeidan, MBBS, MHS is an Associate Professor...

The BCL-2 inhibitor, venetoclax, has transformed the treatment landscape for acute myeloid leukemia (AML), particularly in cases where patients are considered ineligible for intensive...